BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Apoptosis
,
Allergy to pollen
,
Stem cell
,
Hematopoietic cell
,
Phenobarbital
,
rs4950928
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
p38 sapk
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Cervical cancer HeLa cells with siRNA knockdown of SKIIP, treated with osmostressor NaCl
Explore Curated Studies Results
Literature
Most Relevant Literature
Atorvastatin protects against cyclophosphamide-induced thyroid injury in rats via modulation of JNK/…
Dexmedetomidine Alleviates Lipopolysaccharide-Induced Hippocampal Neuronal Apoptosis via Inhibiting …
Anti-Inflammatory Profile of Jungia sellowii Less. by Downregulation of Proinflammatory Mediators an…
Chlorogenic Acid Alleviates Chronic Stress-Induced Intestinal Damage by Inhibiting the P38MAPK/NF-κB…
Role of p38 inhibition in cardiac ischemia/reperfusion injury.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Evaluation of Human Melanocytes After the Use of PRP Versus Fractional CO2 Laser in Vitiligo
Study of the Activation of Proinflammatory Pathways of Toll-like Receptors in Schizophrenia Patients
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ